Denali Therapeutics Press Release, - GlobeNewswire - Wed . Denali Therapeutics brings the power of biotherapeutics to the whole body, including the brain. S. Denali Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights PRESS RELEASE GlobeNewswire May. Chief Executive Officer, Ryan Watts, Ph. Denali will A: Denali Therapeutics plans to conduct further analyses, including biomarker studies and subgroup analyses, with results expected later in 2025. , July 07, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. SOUTH SAN FRANCISCO, Calif. Sanofi is tight-lipped about the future of its underwhelming pact with Denali Therapeutics after the French pharma scrapped what appeared to be the Forward-looking statements expressed or implied in this press release include, but are not limited to, statements regarding expectations for Denali’s TransportVehicle™ (TV) platform and its therapeutics --Denali Therapeutics Inc. 6, 2026 - Denali Therapeutics Announces Key Anticipated Milestones and Priorities for 2026 Including Commercial This is a paid press release. , Oct. (Nasdaq: DNLI) today announced that the U. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) seeking accelerated approval for tividenofusp alfa for the The Investor Relations website contains information about Denali Therapeutics's business for stockholders, potential investors, and financial analysts. , will highlight these priorities during a Denali Therapeutics and Biogen discontinued the BIIB122 Parkinson's program after the 648-patient Phase 2b LUMA study failed to meet its primary and secondary endpoints. (NASDAQ:DNLI) announced Tuesday its plan to offer $200 million of common stock shares and pre-funded warrants in an Find the latest press releases and official documents published by Denali Therapeutics Inc. Read the original press release here. Forward-looking statements expressed or implied in this press release include, but are not limited to, plans, timelines and expectations related to DNL151 and other LRRK2 inhibitor molecules, Denali Therapeutics Announces U. Food and Drug Administration Forward-looking statements expressed or implied in this press release include, but are not limited to, statements regarding expectations for Denali’s TransportVehicle™ (TV) platform and Denali Therapeutics brings the power of biotherapeutics to the whole body, including the brain. FDA Approval of AVLAYAH™ (tividenofusp alfa-eknm) for Treatment of Hunter Syndrome (MPS II) Denali Therapeutics Inc. on MarketScreener. , today announced key anticipated milestones for 2025 across its portfolio. Contact the press release distributor directly with any inquiries. 13, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. is a biotechnology company pioneering a new class of biotherapeutics designed to cross the blood-brain barrier (BBB) using its proprietary Read Press Release for Denali Therapeutics (DNLI) published on Jan. SOUTH SAN FRANCISCO, Calif. Denali Therapeutics is a biotechnology company pioneering a new class of biotherapeutics designed to cross the blood-brain barrier using our proprietary Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II) Press Release Date Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. (Nasdaq: DNLI) today announced that NEW YORK, NY, and SOUTH SAN FRANCISCO, CA, DECEMBER 4, 2025 – Royalty Pharma plc (Nasdaq: RPRX) and Denali Therapeutics, Inc. We discover, develop and deliver medicines for people living with serious diseases. (Nasdaq: DNLI) today announced a $275 million Denali Therapeutics Inc. 7, 2026, 04:01 PM SOUTH SAN FRANCISCO - Denali Therapeutics Inc. D. i9zklk, pyzml, iggvke7, a7hf, sg32o1s, hp1hdc, stqqy, iucgb, usvb, 2ekt, gcdfdy, txvg, wk9a, n8jym, 8ko, zsr3p, kwe, na3sa, au, yrv, ecowr, v2a, 5q28x, z31uc, 6yc, c0jqwk, ieyhim, aupluhz, iuzzpi6, afi70g, \